About 90% of the U.S. population has gotten their two-dose regimen to protect against measles, mumps and rubella, but ...

A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

BRIDGEWATER, NJ, USA I March 14, 2025 I Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug ...

Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced its plans to explore utilizing Molecular Envelope Technology (MET) ...

This year, healthcare centers across the United States face a transformative moment as new regulatory requirements reshape ...

It seeks to promote an interdisciplinary dialogue on innovative strategies, novel vaccine targets, and delivery systems, ultimately highlighting the transformative potential of therapeutic vaccines in ...

The same day, Kennedy appeared on Fox News, saying federal reporting systems for vaccine injuries are insufficient, although adverse reactions are reportable and searchable by the HHS.

Who is most at risk for measles? Unvaccinated children are at risk of getting measles, but so are other people who are not able to get the vaccine or who have compromised immune systems. How does the ...